ClusterFunkAugust 2026We read thousands of research papers each month so you don't have to

← Trend Radar·Biotech·Protein Structure Prediction

Biotech↑ High velocity · top 20%

Protein Structure Prediction

AlphaFold successors predicting not just structure but function and interaction — closing the loop from protein sequence to drug candidate.

Innovators

Early Adopters

Early Majority

Late Majority

▲ Saturation

Papers Analyzed

13,672

research papers

Signal Clusters

research threads

Primary Driver

Tech

strongest force

Paper Coverage

2025–2026

publication years

Intelligence Brief

Saturation

The field is mature. Research has shifted from foundational questions to specialization, efficiency, and integration with adjacent technologies.

This research cluster explores how artificial intelligence, particularly advanced machine learning models, is revolutionizing scientific discovery. By analyzing vast datasets and simulating complex molecular interactions, these AI systems are dramatically accelerating our understanding of fundamental biological processes, such as how proteins fold into their functional shapes. The sheer volume of 4670 papers published between 2023 and 2026 signals a significant, ongoing shift in scientific methodology, moving beyond traditional experimentation to AI driven hypothesis generation and validation. With approximately 90.9% of its potential adoption already reached and peak activity expected in about 4 years, this trend is rapidly maturing. In the short term, expect AI to enhance existing research workflows, speeding up data analysis and hypothesis testing for drug discovery and materials science. In the medium term, as the market matures, we will see AI systems capable of independent scientific reasoning, leading to the design of novel proteins for therapeutics or advanced materials. The primary barrier remains translating these AI driven discoveries into real world applications and overcoming the infrastructural and ethical considerations for broad deployment.

🔒

Full synthesis unlocked with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Research Signals · 12 clusters detected

Saturation● Tech·4,670 papers·+1182.4% MoM

S01

Scientific Discovery

? What if AI could predict your next breakthrough discovery before you even start the experiment, saving years and billions in research and development?

Key Papers

2026Early-life stage phenomic prediction of field agronomic traits across breeding cycles in intermediate wheatgrass↗2026How the layer-dependent ratio of excitatory to inhibitory cells shapes cortical coding in balanced networks↗2026Antifungal Resistance and Adhesin-Mediated Phenotypic Plasticity Among Genomically Diverse Candida auris Clinical Isolates↗

+ 5 more papers with Pro

Adoption Curve

Low confidence · R² 0.46

Phase Position

Adoption Curve

Low confidence · R² 0.46

Saturation— Fully mature, widely used technology

90.9% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Saturation· high adoption, high momentum

90.9% adoption · velocity 100th percentile

Deep Analysis

PEST Implications

Political

Governments may need to consider new regulations for AI-driven research to ensure ethical use and equitable access to discoveries.

Economic

Businesses can expect accelerated innovation and new market opportunities as AI speeds up scientific breakthroughs in areas like medicine and materials.

Social

Advances in understanding complex systems like biological matter could lead to better treatments for diseases and solutions to environmental challenges, improving public health.

Tech

This research is fundamentally reshaping how science is done, leading to powerful new tools that can discover knowledge faster than ever before.

Deeper Signals

Most Active Authors

Y. Li · 33 Y. Wang · 31 Y. Zhang · 29 Y. Chen · 27 Y. Liu · 27

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written, not the Saturation stage the paper-volume model above shows. The papers frequently use terms like "propose," "investigate," "explore," and "develop," indicating a focus on novel research and early-stage application rather than established production.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Majority● Tech·346 papers·+10.0% MoM

S02

Protein Dynamics

? What if we could predict precisely how a drug will interact with a disease-causing protein before it's even synthesized, revolutionizing medicine development and cutting costs dramatically

Key Papers

2026Single-Molecule Nanopore Profiling of p53-TAD Conformational Dynamics, Interactions, and Inhibition↗2026Geometric characterization of the HSV - 1 glycoprotein B - amyloid β interaction in Alzheimer's disease using Forman-Ricci curvature↗2026Distinct Mechanisms for Inhibition of SARS-CoV-2 Main Protease: Dimerization Promoted by Peptidomimetic Inhibitors and Disrupted by Ebselen↗

+ 5 more papers with Pro

Adoption Curve

Moderate confidence · R² 0.79

Phase Position

Adoption Curve

Moderate confidence · R² 0.79

Early Majority— Mainstream adoption is underway

24.5% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Majority· gaining fast, not yet mainstream

24.5% adoption · velocity 95th percentile

Deep Analysis

This research trend centers on understanding and predicting how proteins, the workhorses of our cells, move and change shape. By developing advanced computational tools, scientists can now simulate these dynamic processes with unprecedented detail, moving beyond static structural snapshots. This granular understanding of protein movement is crucial for deciphering biological functions and unlocking new avenues for drug discovery and disease treatment. With peak activity expected within the next one to two years, we will see a rapid advancement in predictive capabilities. Within 12-18 months, expect early adopters in the pharmaceutical and biotechnology industries to integrate these dynamic protein models into their drug design pipelines, accelerating the identification of novel therapeutics. By 2027-2028, these sophisticated simulation techniques will become more accessible, enabling a broader range of researchers to explore complex protein behaviors, though computational cost and the need for experimental validation will remain key barriers.

PEST Implications

Political

Understanding how proteins move could help governments develop faster and more effective treatments for diseases, impacting public health policy.

Economic

Businesses in pharmaceuticals and biotechnology can create more targeted and efficient drugs by predicting protein behavior, leading to new market opportunities and cost savings.

Social

This research could lead to novel therapies for genetic disorders and age-related illnesses, improving the quality of life for many people.

Tech

Advances in computing and AI are enabling scientists to simulate and predict protein movements with unprecedented accuracy, opening doors for new scientific discoveries and engineering applications.

Deeper Signals

Most Active Authors

E. Reading · 2 T. Wang · 2 J. Zhao · 2 Y. Li · 2

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written, not the Early Majority stage the paper-volume model above shows. The papers frequently use terms like "propose," "investigate," "explore," and "discover," indicating a focus on novel methods and initial applications rather than widespread production deployment.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Adopters● Tech·505 papers·+30.0% MoM

S03

Drug Discovery

? What if we could design personalized cures for diseases in days instead of decades, making previously untreatable conditions a thing of the past

Key Papers

2026In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma↗2026A Low Containment CCHFV Entry Screening Platform Identifies Compounds with Antiviral Activity against Authentic CCHFV↗2026Subtyping active-site inhibitor binding mode to Abl kinase using super-resolution nanopore tweezers.↗

+ 5 more papers with Pro

Adoption Curve

Moderate confidence · R² 0.83

Phase Position

Adoption Curve

Moderate confidence · R² 0.83

Early Adopters— Pioneer teams are starting to build with this

10.0% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Adopters· gaining fast, not yet mainstream

10.0% adoption · velocity 95th percentile

Deep Analysis

This research trend centers on the powerful combination of artificial intelligence (AI) and quantum computing to dramatically accelerate drug discovery. By analyzing 505 papers, we see a clear shift from traditional trial-and-error methods to precise, computationally driven approaches that tackle complex biological challenges like predicting how molecules bind to disease targets. This momentum is significant because it promises to unlock faster development of more effective, personalized medicines, addressing the escalating costs and timelines of current drug creation processes. Within the next 1-2 years, expect early adopters, particularly large pharmaceutical companies and specialized AI drug discovery firms, to increasingly integrate advanced AI models and quantum algorithms into their early discovery pipelines for tasks like molecular design and virtual screening. Over the next 3-5 years, as the technology matures and its adoption grows (currently around 10% of projected potential), these methods will become more mainstream, with peak activity anticipated in approximately 5 years, leading to a substantial increase in novel drug candidates entering preclinical development. The primary remaining barriers involve the significant computational resources required, the need for specialized expertise, and ensuring the privacy and security of sensitive training data.

PEST Implications

Political

Governments may need to adapt regulations to address the ethical implications of AI and quantum computing in developing new medicines.

Economic

Businesses investing in these advanced technologies could unlock significant profits by bringing life-saving drugs to market faster and more efficiently.

Social

Patients may benefit from quicker access to more effective and personalized treatments for a wider range of diseases.

Tech

The integration of artificial intelligence and quantum computing promises to revolutionize how we find and create new medicines, making the process faster and more precise.

Deeper Signals

Most Active Authors

Lewis Mervin · 2 Ola Engkvist · 2 Q. Yu · 2 Y. Li · 2 Y. Chen · 2

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written. Papers frequently use terms like "propose," "explore," "accelerated," and "enhancing," indicating a focus on developing and refining new methods rather than widespread production deployment.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Adopters● Tech·155 papers·+20.0% MoM

S04

Disordered Proteins

? What if we could design drugs that precisely target the shifting shapes of disease-causing proteins, making treatments far more effective and with fewer side effects?

Understanding flexible proteins helps create new medicines and materials by revealing how they change shape to perform vital tasks.

Key Papers

2026Predictive all-atom simulations of disordered proteins and biomolecular condensates through osmometry-guided force-field optimization↗2026Emergence of new function through evolutionary divergence of an intrinsically disordered region↗2026BindCORE: Biophysical Ensemble Learning for Predicting Interaction Sites in Intrinsically Disordered Regions↗

+ 5 more papers with Pro

Adoption Curve

High confidence · R² 0.92

Phase Position

Adoption Curve

High confidence · R² 0.92

Early Adopters— Pioneer teams are starting to build with this

10.0% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Adopters· gaining fast, not yet mainstream

10.0% adoption · velocity 86th percentile

PEST Implications

Political

Advances in understanding disordered proteins could lead to new regulations or ethical debates surrounding their use in medicine or biotechnology.

Economic

Businesses in pharmaceuticals and biotechnology may find new opportunities for developing drugs or diagnostic tools targeting these flexible protein structures.

Social

Understanding these proteins could improve treatments for diseases like cancer or Alzheimer's, impacting patient care and public health.

Tech

New computational tools and AI models are being developed, enabling faster and more accurate predictions of protein behavior, which can accelerate scientific discovery.

Deeper Signals

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written. The papers frequently use terms like "propose," "explore," and "uncovering," indicating a focus on developing and evaluating new methods rather than widespread deployment.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Majority● Tech·369 papers

S05

Protein Evolution

? What if we could design entirely new proteins, like custom-built machines, to solve humanity's biggest challenges in medicine and industry tomorrow — imagine cures for diseases we can't touch today or pollution-eating enzymes for a cleaner planet

This research uses advanced methods to understand how proteins change and improve them, leading to new drugs and industrial enzymes.

Key Papers

2026Enrichment-free glycoproteomics harnessing real-time mass defect-driven glycopeptide classification reveals sex differences in murine fucosylation↗2026Single-Molecule Proteomics via a Dynamic Translocase and Physics-Informed Machine Learning↗2026Chromosome-level genome assembly of the European leaf-toed gecko, Euleptes europaea↗

+ 5 more papers with Pro

Adoption Curve

Low confidence · R² 0.00

Phase Position

Adoption Curve

Low confidence · R² 0.00

Early Majority— Mainstream adoption is underway

32.3% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Majority· gaining fast, not yet mainstream

32.3% adoption · velocity 82th percentile

PEST Implications

Political

Governments might support this research to develop new tools for national biosecurity and defense.

Economic

Businesses can create entirely new medicines and industrial enzymes, opening up novel markets and improving efficiency.

Social

Advances in protein design could lead to personalized treatments for diseases and more sustainable industrial processes.

Tech

This research is rapidly accelerating our ability to engineer biological systems, leading to breakthroughs in areas from healthcare to manufacturing.

Deeper Signals

Most Cited Paper

Effective sequence-to-expression prediction for a model membrane protein using machine learning and computational protein design

1 citation

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written, not the Early Majority stage the paper-volume model above shows. The language frequently uses terms like "propose," "explore," and "guided model," indicating a focus on developing and applying new methods rather than widespread production deployment.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Adopters● Political·279 papers·+10.0% MoM

S06

Ligase Regulation

? What if we could precisely control which proteins are active in our bodies to prevent diseases before they even start

This research explores how cells control protein activity, which is key for developing new drugs and therapies for diseases.

Key Papers

2026Substrate Profiling of RNF216 Uncovers a Translation-Linked OTUD4 Regulatory Axis↗2026A small RNA guides a post-transcriptional regulatory protein to its target↗2026Active E. coli heteromeric acetyl-CoA carboxylase forms polymorphic helical tubular filaments↗

+ 5 more papers with Pro

Adoption Curve

Low confidence · R² 0.00

Phase Position

Adoption Curve

Low confidence · R² 0.00

Early Adopters— Pioneer teams are starting to build with this

5.0% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Adopters· gaining fast, not yet mainstream

5.0% adoption · velocity 77th percentile

PEST Implications

Political

Understanding how proteins are regulated by ligases could inform government policies on drug development and public health initiatives.

Economic

New therapies targeting protein degradation could create significant market opportunities for pharmaceutical and biotechnology companies.

Social

Advances in this area may lead to novel treatments for diseases, improving patient quality of life and reducing healthcare burdens.

Tech

This research drives the development of sophisticated biological tools and platforms for designing targeted therapies.

Deeper Signals

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written. The language uses terms like "design principles," "inference," "prediction," and "de novo design," suggesting exploration and development of new methods rather than established, scaled applications.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Adopters● Tech·178 papers·+10.0% MoM

S07

Chaperone Cycles

? What if we could unlock the secrets of protein folding to prevent or even reverse the cellular breakdown that causes devastating diseases like Alzheimer's and Parkinson's, revolutionizing healthcare and extending healthy lifespans?

This research maps how proteins help other proteins fold correctly, crucial for developing new medicines and therapies for diseases.

Key Papers

2026Polo-like kinase phosphorylation of the orphan kinesin KIN-G negatively regulates centrin arm biogenesis in Trypanosoma brucei↗2026TBC-2, a Rab GTPase activating protein, regulates the localization of the HLH-30/TFEB and PQM-1 transcription factors in the C. elegans intestine↗2026GPCR-Ga13 signaling regulates survival of intestinal intraepithelialCD8 lymphocytes through migration to cytokine-rich niches↗

+ 5 more papers with Pro

Adoption Curve

Low confidence · R² 0.00

Phase Position

Adoption Curve

Low confidence · R² 0.00

Early Adopters— Pioneer teams are starting to build with this

5.0% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Adopters· gaining fast, not yet mainstream

5.0% adoption · velocity 77th percentile

PEST Implications

Political

Understanding how proteins fold and interact could lead to new ways to combat diseases that affect national health systems.

Economic

Discovering how to control protein behavior might unlock more efficient manufacturing processes for medicines and industrial materials.

Social

Insights into protein malfunctions could help develop treatments for neurodegenerative diseases, improving quality of life for many.

Tech

This research paves the way for designing new molecular tools that can precisely control biological processes within cells.

Deeper Signals

Most Cited Paper

DnaJB1 chaperone inhibits tau aggregation by recognizing its N-terminus

2 citations

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written. The language primarily uses verbs like "inhibits," "regulates," "influences," and "induces," suggesting the exploration and demonstration of mechanisms rather than large-scale implementation.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Adopters● Tech·299 papers·+20.0% MoM

S08

DNA Binding

? What if we could precisely reprogram cellular behavior by directly instructing our DNA, unlocking cures for diseases and revolutionizing how we live.

This research explores how molecules interact with DNA to control biological processes, potentially leading to new drugs and therapies.

Key Papers

2026Chemoproteomic profiling of Plasmodium falciparum Hsp90 inhibition reveals functional link to DNA replication pathways↗2026Establishing Design Principles for CRISPR-Cas Antifungals in Candida albicans↗2026Stationary phase KCl levels trigger changes in Dps conformation to facilitate its partitioning between reversibly-aggregated deposits and Dps-DNA condensates↗

+ 5 more papers with Pro

Adoption Curve

Low confidence · R² 0.00

Phase Position

Adoption Curve

Low confidence · R² 0.00

Early Adopters— Pioneer teams are starting to build with this

5.0% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Adopters· gaining fast, not yet mainstream

5.0% adoption · velocity 77th percentile

PEST Implications

Political

Governments may need to consider new regulations for synthetic DNA applications in areas like biosecurity or environmental monitoring.

Economic

Businesses in pharmaceuticals and biotechnology could develop novel diagnostics and therapies by understanding how DNA interacts with other molecules.

Social

Advances in DNA binding research might lead to personalized medicine, offering tailored treatments for genetic diseases and conditions.

Tech

This field is driving the creation of powerful AI tools that can design custom DNA sequences for diverse applications, from drug development to environmental cleanup.

Deeper Signals

Most Active Authors

A. Franchitto · 2 P. Pichierri · 2 S. Wang · 2

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written. The language frequently uses terms like "propose," "design," "prediction," and "advancing," indicating a focus on developing and exploring new methods rather than established, scaled applications.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Adopters● Tech·400 papers·+10.0% MoM

S09

Structural Complexes

? What if understanding the intricate blueprints of our cells' molecular machinery could unlock treatments for devastating diseases or create entirely new bio-based industries?

This research reveals how complex biological machines are built and function, crucial for developing new medicines and biotechnologies.

Key Papers

2026Identification and structural basis of a Chloroflexus protein with homology to Bacillus quorum sensing-related prenyltransferase↗2026Structural basis of endogenous lipid recognition and G protein selectivity in GPR119↗2026Structural basis for nutrient-activated channel opening in bacterial spore germination receptors↗

+ 5 more papers with Pro

Adoption Curve

Low confidence · R² 0.00

Phase Position

Adoption Curve

Low confidence · R² 0.00

Early Adopters— Pioneer teams are starting to build with this

5.0% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Adopters· gaining fast, not yet mainstream

5.0% adoption · velocity 77th percentile

PEST Implications

Political

Understanding how biological structures fit together can inform national strategies for public health preparedness and biosecurity.

Economic

Companies can develop more effective drugs and treatments by precisely designing molecules that interact with specific biological targets.

Social

Advances in understanding protein structures could lead to new therapies for diseases and improved diagnostic tools for healthcare.

Tech

This research drives innovation in computational tools and artificial intelligence for predicting and designing complex biological assemblies.

Deeper Signals

Most Active Authors

Y. Gao · 2

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written. The papers frequently use terms like "improving," "enhanced," "advanced method," and "structural modeling," indicating a focus on refining and applying existing technologies rather than established production use.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Adopters● Tech·389 papers

S10

Protein Design

? What if we could engineer entirely new proteins to cure diseases that currently have no treatment or to create materials with unimaginable properties

This research cluster designs new proteins to create innovative medicines and biological tools, offering significant business opportunities.

Key Papers

2026Inhibition of release of intestinal extracellular vesicles in Ascaris suum and immune modulation by the anthelminthic, ivermectin↗2026High-variance phenome database reveals important roles of WD40 proteins in the plant pathogenic fungus Fusarium graminearum↗2026MR1 dependent MAIT cell activation is regulated by autophagy associated proteins↗

+ 5 more papers with Pro

Adoption Curve

Low confidence · R² 0.00

Phase Position

Adoption Curve

Low confidence · R² 0.00

Early Adopters— Pioneer teams are starting to build with this

5.0% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Adopters· gaining fast, not yet mainstream

5.0% adoption · velocity 77th percentile

PEST Implications

Political

Governments may need to consider new regulations as advanced protein design could impact agriculture and medicine.

Economic

Businesses can develop novel drugs and materials, creating new markets and improving existing products.

Social

Advances in protein design offer potential for new treatments for diseases and improved food production, benefiting public health.

Tech

This research is rapidly advancing our ability to create entirely new proteins with specific functions, revolutionizing fields from manufacturing to healthcare.

Deeper Signals

Most Cited Paper

Non-standard proteins in the lens of AlphaFold 3 - a case study of amyloids

12 citations

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written. The papers frequently use terms like "propose," "explore," "design," and "predict," indicating a focus on novel research and development rather than established, scaled applications.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Adopters● Tech·414 papers·+40.0% MoM

S11

Membrane Proteins

? What if we could design tiny, targeted gates in our cells to precisely control the flow of nutrients and signals, revolutionizing how we treat diseases and enhance human health

This research explores how cell membranes control vital processes, offering potential for new drug targets and therapies for diseases.

Key Papers

2026Cyclic tetra-adenylate triggers Cap1 membrane pore opening and depolarization during the type III CRISPR immune response↗2026Activation of the bridge-like lipid transfer protein Atg2 by Atg1-mediated phosphorylation↗2026Imaging and quantifying cytoplasmic tail dynamics of membrane receptors in living cells↗

+ 5 more papers with Pro

Adoption Curve

Low confidence · R² 0.00

Phase Position

Adoption Curve

Low confidence · R² 0.00

Early Adopters— Pioneer teams are starting to build with this

5.0% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Adopters· gaining fast, not yet mainstream

5.0% adoption · velocity 77th percentile

PEST Implications

Political

Understanding how membrane proteins function could lead to new regulations for drug safety and efficacy.

Economic

Advances in membrane protein research may unlock new markets for pharmaceuticals and biotechnology companies.

Social

Improved drug delivery systems targeting membrane proteins could lead to better treatments for diseases affecting many people.

Tech

New tools and techniques developed in this field will enable the creation of innovative biosensors and advanced diagnostics.

Deeper Signals

Most Active Authors

G. Hummer · 3 J. Zhang · 2 Y. Lu · 2 S. Martens · 2 A. Kumar · 2

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written. The papers frequently use terms like "design," "prediction," "enhances," and "improves," indicating a focus on developing and refining new methods and understanding rather than established, widespread application.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Early Adopters● Tech·309 papers·+20.0% MoM

S12

Biomolecular Condensates

? What if we could precisely control where and how proteins assemble in our cells to instantly fix disease-causing malfunctions or boost our natural defenses

Understanding how biological molecules form and behave in liquid-like droplets can unlock new ways to develop drugs and therapies for diseases.

Key Papers

2026Heterotypic interactions and sequence features modulate cellular reflectin condensate dynamics↗2026Towards transferable explicit-solvent coarse-grained models for biomolecular condensates↗2026HP1 dimerization drives the condensation and segregation of H3K9me-marked chromatin↗

+ 5 more papers with Pro

Adoption Curve

Low confidence · R² 0.00

Phase Position

Adoption Curve

Low confidence · R² 0.00

Early Adopters— Pioneer teams are starting to build with this

5.0% of projected market reached

Peak timing · · · Pro

Hover the chart to explore adoption over time

Phase Position

Early Adopters· gaining fast, not yet mainstream

5.0% adoption · velocity 77th percentile

PEST Implications

Political

Governments may need to consider new regulations for advanced biological therapies developed using these techniques.

Economic

Companies developing new drugs and treatments could see faster development cycles and potentially lower costs.

Social

Patients may benefit from more effective and personalized treatments for diseases like cancer.

Tech

This research is driving innovation in how we design and understand complex biological molecules, opening doors for new scientific tools.

Deeper Signals

Most Active Authors

A. Busch · 2 Y. Jensen · 2 B. Bogdanow · 2 L. Muehlberg · 2 L. Wiebusch · 2

Maturity, From the Writing Itself

Reads as Early Adopters based on how these papers are written. The language frequently uses terms like "de novo design," "accelerated," "prediction," and "evaluation," indicating a focus on developing and testing new methods and tools rather than widespread production deployment.

🔒

Full analysis with Pro

Narrative · PEST analysis · Convergence scenarios · Archive

Subscribe · $39 / month

Cancel anytime · Annual plan $390/yr

Research Momentum

+18% year-over-year(2025 → 2026, sample papers)

Based on representative paper sample per cluster · not a complete count

Stage Breakdown

Share of papers per adoption stage, weighted by cluster size.

Early Adopters21%

Early Majority5%

Saturation34%

Related Trends · Biotech

●CRISPR Gene Editing ●Gene Therapy & mRNA Medicine ●Synthetic Biology ●Spatial Omics & Cell Atlas ●Longevity & Aging Biology

← Back to Trend Radar